Posts Tagged ‘length of use’

Can the Common Aspirin Lower the Risk of Melanoma?

Friday, March 22nd, 2013

logo1267406_mdA new study published early online in Cancer concluded that women who take aspirin have a reduced risk of developing melanoma, and the longer they take it, the lower the risk. It seems possible that the anti-inflammatory effects of aspirin may help protect against melanoma.

As part of the women’s Health Initiative researchers observed women between ages 50 and 79 for an average of 12 years and determined which developed cancer. At the beginning of observations women were asked medications being taken, foods they ate, and activities they performed.

They found that of the 59,806 Caucasian women included those who took the most aspirins were less likely to develop melanoma skin cancer during the twelve years in relation to those who did not take aspirins. Overall women who used aspirin has a 21% lower risk of melanoma and each incremental increase in duration of aspirin use (less than one year of use, one to four years of use, and five or more years of use) was associated with an 11% lower risk of melanoma. Consequently, women who used aspirin for five or more years had a 30% lower risk for melanoma than women who did not use aspirin. Differences in pigmentation, tanning practices, sunscreen use, and other factors that may affect skin cancer were controlled for. The researcher concluded that “Aspirin works by reducing inflammation and this may be why using aspirin may lower your risk of developing melanoma. “